9 results
treatment diagnosis hivaids idsa neurology opportunistic syndrome aimovig barre capsulatum cryptococcosis cryptococcus differential dosing encephalopathy erenumab fungal guillain guillainbarre herpessimplex
Guillain-Barre Syndrome - Summary Acute AIDP that presents with rapidly progressive flaccid weakness Epidemiology: • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... response preceding infection ... Can begin in arms ... Syndrome #diagnosis #management ... #treatment #neurology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview Clinico-Radiological Syndrome, characterized by: • Headache • Seizures • Altered mental
Etiology: • Pathophysiology ... sequences improve sensitivity ... Diagnosis: • Infection ... Syndrome #diagnosis #management ... #neurology
Transverse Myelitis Overview Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... Direct microbial infection ... Hyperreflexia develops later ... Myelitis #diagnosis #management ... #neurology #differential
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV) Infections ... After lesions begin ... HerpesSimplex #HSV #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
Recommendations for Preventing ... Histoplasma Capsulatum Infections ... a hyperendemic rate ... #Treatment #management ... #HIVAIDS #pharmacology
Aimovig (Erenumab) Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist Indication: Preventive Treatment of Migraines: Dosing: 70 mg SQ monthly,
Indication: Preventive ... primary side effects being ... injection site ... Erenumab #Migraine #Neurology ... #Pharmacology #
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS Early Stage (Primary, Secondary,
1 dose (BII) Late-Latent ... 28 days (BIII) Late-Stage ... pallidum #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS Treatment for cryptococcosis consists of 3 phases: induction,
Recommendations for Preventing ... Therapy) • To begin ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Mycoses HISTOPLASMOSIS • Inhalation of conidia → Yeast → travel to lymph nodes → spread in body • Bird
antigen assay has a sensitivity ... Aspergillosis Pathophysiology ... shock • Mortality rate ... Fungal #Diagnosis #Management ... #Infections
No results found for "late pathophysiology sensitivity nephrology pharmacology benign management infections prevention"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #late #pathophysiology #sensitivity #nephrology #pharmacology #benign #management #infections #prevention